Interstitial Brachytherapy of Malignant Gliomas: The Memorial Sloan-Kettering Cancer Center Experience
Malignant gliomas remain incurable primary brain tumors despite the dedicated efforts over many decades of hundreds of clinical scientists worldwide. Any new procedure that offers a rationale for better tumor control is seized upon and applied in the hope that theory can be translated into practice, and that treatment can be translated into longer survival. One of these new techniques is interstitial brachytherapy, the stereotactic implantation of radioactive seeds directly into the tumor. In Europe this technique has been most widely applied to the treatment of low-grade gliomas, as discussed by Dr. Ostertag at this symposium. In North America the emphasis during the past 10 years has been on the application of this method to the treatment of malignant gliomas. In 1990 at least 50 institutions in North America were licensed by the manufacturer of 125I seeds to treat patients with brain tumors. This chapter reviews the experience with interstitial brachytherapy at Memorial Sloan-Kettering Cancer Center since 1986.
KeywordsMalignant Glioma Radiation Necrosis Karnofsky Performance Score Compute Tomo Interstitial Brachytherapy
Unable to display preview. Download preview PDF.
- Larson DA, Gutin PH, Leibel SA, Phillips TL, Sneed PK, Wara WM (1990) Stereotaxic irradiation of brain tumors. Cancer 65: 792 799Google Scholar
- Saw CB, Suntharalingham N, Ayyangar KM, Tupchong L (1989) Dosimetric considerations of stereotactic brain implants. hit J Radiat Oncol Biol Phys 17: 887–891Google Scholar
- Szikla G, Schlienger M, Blond S, Daumas-Duport C, Missir O, Miyahara S, Musolino A, Schaub C (1984) Interstitial and combined interstitial and external irradiation of supratentorial gliomas Results in 61 cases treated 1973–1981. Acta Neurochir Suppl 33: 355–362Google Scholar
- Ten Haken RK, Diaz RF, McShan DL, Fraass BA, Taren JA, Hood TW (1988) From manual to 3-D computerized treatment planning for 125I stereotactic brain implants. hit J Radiat Oncol Biol Phys 15: 467–480Google Scholar